US 9957292
Compositions and methods for modulating angiopoietin-like 3 expression
granted A61PA61P3/00A61P3/04
Quick answer
US patent 9957292 (Compositions and methods for modulating angiopoietin-like 3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 81
- CPC classes
- A61P, A61P3/00, A61P3/04, A61P3/06, A61P3/10